Chemokine receptor binding heterocyclic compounds with...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4709 (2006.01) A61P 7/00 (2006.01) A61P 9/00 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2522535

The invention relates to heterocyclic compounds consisting of a core nitrogen atom surrounded by three pendant groups, wherein two of the three pendant groups are preferably benzimidazolyl methyl and tetrahydroquinolyl, and the third pendant group contains N and optionally contains additional rings. The compounds bind to chemokine receptors, including CXCR4 and CCR5, and demonstrate protective effects against infections of target cells by a human immunodeficiency virus (HIV).

L'invention concerne des composés hétérocycliques constitués d'un atome azote de coeur entouré de trois groupes pendants, dans lesquels deux des trois groupes pendants sont de préférence benzimidazolyl méthyle et tétrahydroquinolyle, et le troisième groupe pendant contient N et il contient facultativement des cycles additionnels. Les composés se fixent aux récepteurs de la chimiokine, y compris CXCR4 et CCR5, et ils présentent des effets protecteurs contre l'infection de cellules cibles par un virus d'immunodéficience humaine (VIH).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Chemokine receptor binding heterocyclic compounds with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chemokine receptor binding heterocyclic compounds with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemokine receptor binding heterocyclic compounds with... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1422145

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.